As contributing writer, Ann currently reports on the health care and life sciences industries for trade magazines and online news services. The Garden State Journalists presented Ann with its Health and Science Award in 2007 for her behind-the-scenes feature article about clinical trials in NJ. Her 200-page syndicated report titled " US Cholesterol-Lowering Drugs 2005: A Market Analysis" was published by an international market research firm. Ann also updated the market studies "Nonprescription Drugs USA -- 2012" and "2008 Global Outlook for Specialty Excipients." She has written news and feature articles about new branded and generic medicines, OTC drugs, FDA compliance, health care reform, counterfeit drugs, R&D pipelines, clinical trials, financial results, patient care, law suits, sales force automation, and CROs.

Ann wrote daily news stories about breaking developments in the US pharmaceutical and biotech industries. "Scrip," a weekly newsletter and daily online service, is based in the UK. For background on stories, she attended press conferences, traveled to meetings and researched Internet databases. Her duties as US Reporter included the ongoing monitoring of news involving products, issues and trends. Her stories were on a range of topics:* evolving US health care policies; * FDA's prescription drug approvals and withdrawals; * generic drugs and biosimilars;* lawsuits against/by pharma firms; * breakthrough research affecting medications;* profiles of emerging biotech firms; * company research & development pipelines; * OTC drug switch products and dietary supplements; and* quarterly financial results and merger activities.

Wrote about news, issues and trends for trade magazines owned by the Financial Times including "OTC Business News," "Pharmaceutical Business News" and "Medical Device Business News."